According to Relmada Therapeutics's latest financial reports the company's current earnings (TTM) are -โน7.28 B. In 2023 the company made an earning of -โน8.29 B an increase over its 2022 earnings that were of -โน13.18 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.